CBP Intercepts Shipments of Unapproved Injectable Cosmetics

CINCINNATI—Throughout the first month of 2022, Cincinnati U.S. Customs and Border Protection (CBP) officers seized 11 shipments of unapproved cosmetic treatments such as Botox, Juvederm, Restylane, and other fillers. Injectable cosmetic treatments are regulated by U.S. Food and Drug Administration (FDA), because unapproved products can contain unknown ingredients that may be ineffective or dangerous.

Unapproved Botox (image credit: CBP)

The 11 illegal shipments originated in China, South Korea, Bulgaria, and Czech Republic with ultimate destinations in many states including Florida, Texas, and New Mexico. The largest shipment, which came from China, contained 100 vials of Botox botulinum vials—or about 12,500 injections.  Had the products been genuine and FDA-approved, the combined value for all the prohibited injectables would have been $170,545.

The shipments CBP seized in Cincinnati included these injectables:

  • Botox
  • Juvederm
  • Restylane
  • Sardenya
  • Yvoire
  • Rejeunesse
  • Meditoxin
  • Sculptra

CBP works in conjunction with FDA to intercept illegal shipments like these from entering the commerce of the United States. Consumers may think they are getting a “great deal” by purchasing cosmetic treatments online from third party sellers, but it is impossible to determine the products’ safety, efficacy, or legitimacy. CBP recommends consumers purchase regulated cosmetic products from reputable sources, and ensure they are administered by properly trained and licensed medical professionals.